Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

MDxHealth (MDXH) Return on Sales (2022 - 2025)

Historic Return on Sales for MDxHealth (MDXH) over the last 5 years, with Q3 2025 value amounting to 0.29%.

  • MDxHealth's Return on Sales rose 1600.0% to 0.29% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.3%, marking a year-over-year increase of 1900.0%. This contributed to the annual value of 0.42% for FY2024, which is 1900.0% up from last year.
  • MDxHealth's Return on Sales amounted to 0.29% in Q3 2025, which was up 1600.0% from 0.28% recorded in Q2 2025.
  • MDxHealth's Return on Sales' 5-year high stood at 2969.6% during Q2 2022, with a 5-year trough of 1.39% in Q3 2021.
  • Moreover, its 5-year median value for Return on Sales was 0.52% (2024), whereas its average is 174.01%.
  • Within the past 5 years, the most significant YoY rise in MDxHealth's Return on Sales was 8000bps (2023), while the steepest drop was -29702300bps (2023).
  • Quarter analysis of 5 years shows MDxHealth's Return on Sales stood at 1.34% in 2021, then rose by 30bps to 0.95% in 2022, then soared by 42bps to 0.55% in 2023, then surged by 51bps to 0.27% in 2024, then decreased by -7bps to 0.29% in 2025.
  • Its Return on Sales was 0.29% in Q3 2025, compared to 0.28% in Q2 2025 and 0.37% in Q1 2025.